| Patient | Josephine Baker |
|---|---|
| Date of birth | 1906-06-03 |
| Identifiers | MRN HR-ML049-SYN-TD; SSN (made up) 000-49-3172 |
| Document date | 2026-11-01 |
| Author | Colette Ashby-Nwosu, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Establishing care three weeks after a heart attack and stent, with breathlessness on exertion and tiredness: examination, ECG, laboratory tests, medicines, mood screening, cardiac rehabilitation and the chest-pain action plan. Concerns: She wants to return to the stage and to have the strength to care for her children; She is afraid of another heart attack and of what would happen to her family; Debts and lost income make every cost a worry. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Aspirin 81 mg delayed-release oral tablet, one tablet daily | One tablet daily | Oral route | 1969-03-24 | active | S |
| Ticagrelor 90 mg oral tablet, one tablet twice daily | One tablet twice daily | Oral route | 1969-03-24 to 1969-04-28 | completed | S |
| Clopidogrel 75 mg oral tablet: a 600 mg loading dose (eight tablets) 24 hours after the last ticagrelor, then one tablet daily | One tablet daily after a 600 mg loading dose | Oral route | 1969-04-28 | active | S |
| Atorvastatin 80 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1969-03-24 | active | S |
| Metoprolol succinate 25 mg extended-release oral tablet, one tablet daily | One tablet daily | Oral route | 1969-03-24 | active | S |
| Lisinopril 5 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1969-03-24 to 1969-04-28 | completed | S |
| Lisinopril 10 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1969-04-28 | active | S |
| Nitroglycerin 0.4 mg sublingual tablet, one tablet under the tongue every 5 minutes as needed for chest pain, up to 3 tablets; call 911 if the pain is not better 5 minutes after the first tablet | One tablet under the tongue every 5 minutes as needed for chest pain, up to 3 doses | Sublingual route | 1969-03-24 | active | S |
| Procedure | Dates | Status | Evidence |
|---|---|---|---|
| Coronary angiography and percutaneous coronary intervention in the hospital for a non-ST-elevation myocardial infarction: 90% stenosis of the mid right coronary artery treated with one drug-eluting stent; mild disease elsewhere. Performed at a regional hospital before she established care | 1969-03-24 to 1969-03-24 | completed | S |
| Twelve-lead electrocardiogram: sinus rhythm at 64 per minute, small Q waves in II, III and aVF from the recent inferior infarction, no acute ST change, normal QT | 1969-04-14 to 1969-04-14 | completed | S |
| Outpatient cardiac rehabilitation, phase 2: 36 sessions over twelve weeks with exercise training, nutrition, stress management and psychological support; all sessions completed | 1969-04-21 to 1969-07-17 | completed | S |
| Transthoracic echocardiography: ejection fraction 52%, hypokinesis of the basal and mid inferior wall, normal right ventricle, no thrombus, normal valves, normal estimated filling pressures, no pericardial effusion | 1969-04-28 to 1969-04-28 | completed | S |
| Symptom-limited exercise treadmill test on her usual medicines (Bruce protocol): 9 minutes, about 10 METs, peak heart rate 132 per minute on metoprolol, normal blood pressure response (124/76 to 172/80), no angina, no ischemic ST change, no arrhythmia | 1969-07-21 to 1969-07-21 | completed | S |
| Advance care planning conversation, about 20 minutes, with her consent | 1969-09-15 to 1969-09-15 | completed | S |
| Date | Vaccine | Status | Evidence |
|---|---|---|---|
| 1969-09-15 | Influenza vaccine, this season | completed | S |
| 1969-09-15 | COVID-19 vaccine, mRNA, this season | completed | S |
| 1969-09-15 | Pneumococcal conjugate vaccine PCV20, single dose | completed | S |
| 1969-10-20 | Respiratory syncytial virus vaccine, single dose | completed | S |
| 1969-10-20 | Recombinant zoster vaccine, dose 1 of 2 | completed | S |
| 1969-10-20 | Tetanus, diphtheria, and acellular pertussis vaccine (Tdap) | completed | S |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| June 1941 to December 1942 | Long, grave illness in Casablanca after the loss of a pregnancy: in bed in hospital from June 1941 to December 1942, with five operations, reportedly including an emergency hysterectomy, and peritonitis and septicemia (details from one secondary source; stillbirth or miscarriage disputed) | R (CLM-0007, CLM-0008) |
| March 1969 | Heart attack in March 1969, on the day of her eviction from Les Milandes, with admission to hospital in Périgueux; described as a new heart attack, with any earlier one undated in the sources read | D (CLM-0011) |
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
| Concern | Status | Evidence |
|---|---|---|
| She wants to return to the stage and to have the strength to care for her children | active | S |
| She is afraid of another heart attack and of what would happen to her family | active | S |
| Debts and lost income make every cost a worry | active | S |
Most recent measures: Hemoglobin [Mass/volume] in Blood 12.4 on 1969-10-20; Platelets [#/volume] in Blood by Automated count 258 on 1969-06-16; Sodium [Moles/volume] in Serum or Plasma 139 on 1969-10-20; Potassium [Moles/volume] in Serum or Plasma 4.5 on 1969-10-20; Creatinine [Mass/volume] in Serum or Plasma 0.84 on 1969-10-20; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1964)/1.73 sq M 78 on 1969-10-20; Glucose [Mass/volume] in Serum or Plasma 93 on 1969-10-20; Cholesterol [Mass/volume] in Serum or Plasma 128 on 1969-07-21; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 62 on 1969-07-21; Cholesterol in HDL [Mass/volume] in Serum or Plasma 54 on 1969-07-21; Triglyceride [Mass/volume] in Serum or Plasma 72 on 1969-07-21; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 22 on 1969-07-21; Hemoglobin A1c/Hemoglobin.total in Blood 5.6 on 1969-04-14; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 1969-09-15; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 3 on 1969-07-21; Overall summary score [SAQ] 96 on 1969-10-20; Lipoprotein a [Moles/volume] in Serum or Plasma 172 on 1969-04-28; Left ventricular Ejection fraction 52 on 1969-04-28; Total score [AUDIT-C] 1 on 1969-09-15 [S]
Strengths and supports: engagement in care [S]
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Breathlessness on exertion and tiredness since discharge three weeks after the heart attack, without chest pain at rest; cause to be determined (heart function, ischemia, anemia, medicine effect or deconditioning) | resolved | confirmed | R06.09 | S — Synthetic presenting problem, resolved at the second visit when the echocardiogram and cardiology attributed it to ticagrelor. |
| Coronary artery disease after a non-ST-elevation myocardial infarction three weeks before intake, treated with one drug-eluting stent to the right coronary artery; synthetic modern episode linked to the documented heart attack of March 1912 | active | confirmed | I25.10 | S — Synthetic modern diagnosis; the 1969 heart attack remains D in the history. |
| High blood pressure, found during the hospital stay for the heart attack | active | confirmed | I10 | S — Synthetic modern diagnosis; no claim about her real blood pressure. |
| Absence of the uterus after an emergency hysterectomy at about 35, during a long, grave illness after the loss of a pregnancy; whether the ovaries were removed is not known; counted as a possible early menopause when weighing her cardiovascular risk | active | provisional | Z90.710 | S — Synthetic modern status linked to the retrospective account of a hysterectomy in 1941 or 1942; the operation itself rests on one secondary source. |
| Breathlessness from ticagrelor: a common, harmless side effect, resolved after the change to clopidogrel | resolved | confirmed | T45.525A | S — Synthetic diagnosis at the second visit; resolved at the third visit after the switch. |
| Raised lipoprotein(a), 172 nmol/L, an inherited risk-enhancing factor | active | confirmed | E78.41 | S — Synthetic result measured once at the second visit. |
| Financial strain: heavy debts after the loss of her home and estate, with income only from performing, which she has stopped while she recovers | active | confirmed | Z59.86 | S — Synthetic social need anchored to her documented debts and the loss of Les Milandes. |
| Anterior nosebleed from the left side of the nose, lasting about 25 minutes, in dry weather on aspirin and clopidogrel; stopped with pressure; no further bleeding | resolved | confirmed | R04.0 | S — Synthetic intercurrent problem at an unscheduled visit; it follows from dual antiplatelet therapy and does not echo a documented illness. |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1969-04-14 | Hemoglobin [Mass/volume] in Blood | 12.2 | g/dL | 11.6-15 g/dL | Normal | S |
| 1969-04-14 | Platelets [#/volume] in Blood by Automated count | 264 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 1969-04-14 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 1969-04-14 | Potassium [Moles/volume] in Serum or Plasma | 4.4 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1969-04-14 | Creatinine [Mass/volume] in Serum or Plasma | 0.82 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 1969-04-14 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1964)/1.73 sq M | 81 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1969-04-14 | Glucose [Mass/volume] in Serum or Plasma | 94 | mg/dL | 70-99 mg/dL | Normal | S |
| 1969-04-14 | Cholesterol [Mass/volume] in Serum or Plasma | 152 | mg/dL | <=199 mg/dL | Normal | S |
| 1969-04-14 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 84 | mg/dL | Secondary-prevention goal below 70 mg/dL | High | S |
| 1969-04-14 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 52 | mg/dL | >=50 mg/dL | Normal | S |
| 1969-04-14 | Triglyceride [Mass/volume] in Serum or Plasma | 80 | mg/dL | <=149 mg/dL | Normal | S |
| 1969-04-14 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 24 | U/L | 7-35 U/L | Normal | S |
| 1969-04-14 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.6 | % | <=5.6% | Normal | S |
| 1969-04-14 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 2 | {score} | S | ||
| 1969-04-14 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 7 | {score} | S | ||
| 1969-04-14 | Overall summary score [SAQ] | 70 | {score} | S | ||
| 1969-04-28 | Lipoprotein a [Moles/volume] in Serum or Plasma | 172 | nmol/L | 125 nmol/L or higher is a risk-enhancing level | High | S |
| 1969-04-28 | Left ventricular Ejection fraction | 52 | % | 50-70% | Normal | S |
| 1969-05-26 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 135-145 mmol/L | Normal | S |
| 1969-05-26 | Potassium [Moles/volume] in Serum or Plasma | 4.7 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1969-05-26 | Creatinine [Mass/volume] in Serum or Plasma | 0.88 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 1969-05-26 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1964)/1.73 sq M | 74 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1969-05-26 | Glucose [Mass/volume] in Serum or Plasma | 92 | mg/dL | 70-99 mg/dL | Normal | S |
| 1969-05-26 | Overall summary score [SAQ] | 84 | {score} | S | ||
| 1969-06-16 | Hemoglobin [Mass/volume] in Blood | 11.9 | g/dL | 11.6-15 g/dL | Normal | S |
| 1969-06-16 | Platelets [#/volume] in Blood by Automated count | 258 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 1969-07-21 | Cholesterol [Mass/volume] in Serum or Plasma | 128 | mg/dL | <=199 mg/dL | Normal | S |
| 1969-07-21 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 62 | mg/dL | Secondary-prevention goal below 70 mg/dL | Normal | S |
| 1969-07-21 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 54 | mg/dL | >=50 mg/dL | Normal | S |
| 1969-07-21 | Triglyceride [Mass/volume] in Serum or Plasma | 72 | mg/dL | <=149 mg/dL | Normal | S |
| 1969-07-21 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 22 | U/L | 7-35 U/L | Normal | S |
| 1969-07-21 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 3 | {score} | S | ||
| 1969-07-21 | Overall summary score [SAQ] | 94 | {score} | S | ||
| 1969-09-15 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S | ||
| 1969-10-20 | Hemoglobin [Mass/volume] in Blood | 12.4 | g/dL | 11.6-15 g/dL | Normal | S |
| 1969-10-20 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 1969-10-20 | Potassium [Moles/volume] in Serum or Plasma | 4.5 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1969-10-20 | Creatinine [Mass/volume] in Serum or Plasma | 0.84 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 1969-10-20 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1964)/1.73 sq M | 78 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1969-10-20 | Glucose [Mass/volume] in Serum or Plasma | 93 | mg/dL | 70-99 mg/dL | Normal | S |
| 1969-10-20 | Overall summary score [SAQ] | 96 | {score} | S | ||
| 1969-09-15 | Total score [AUDIT-C] | 1 | {score} | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1969-04-14 | Body height | 168 | cm | S |
| 1969-04-14 | Body weight | 59.8 | kg | S |
| 1969-04-14 | Body mass index (BMI) [Ratio] | 21.2 | kg/m2 | S |
| 1969-04-14 | Systolic blood pressure | 138 | mm[Hg] | S |
| 1969-04-14 | Diastolic blood pressure | 84 | mm[Hg] | S |
| 1969-04-14 | Heart rate | 64 | /min | S |
| 1969-04-14 | Respiratory rate | 16 | /min | S |
| 1969-04-14 | Body temperature | 36.6 | Cel | S |
| 1969-04-14 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1969-04-28 | Body height | 168 | cm | S |
| 1969-04-28 | Body weight | 59.6 | kg | S |
| 1969-04-28 | Body mass index (BMI) [Ratio] | 21.1 | kg/m2 | S |
| 1969-04-28 | Systolic blood pressure | 136 | mm[Hg] | S |
| 1969-04-28 | Diastolic blood pressure | 82 | mm[Hg] | S |
| 1969-04-28 | Heart rate | 62 | /min | S |
| 1969-04-28 | Respiratory rate | 16 | /min | S |
| 1969-04-28 | Body temperature | 36.7 | Cel | S |
| 1969-04-28 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1969-05-26 | Body height | 168 | cm | S |
| 1969-05-26 | Body weight | 59.9 | kg | S |
| 1969-05-26 | Body mass index (BMI) [Ratio] | 21.2 | kg/m2 | S |
| 1969-05-26 | Systolic blood pressure | 126 | mm[Hg] | S |
| 1969-05-26 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 1969-05-26 | Heart rate | 60 | /min | S |
| 1969-05-26 | Respiratory rate | 14 | /min | S |
| 1969-05-26 | Body temperature | 36.6 | Cel | S |
| 1969-05-26 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 1969-07-21 | Body height | 168 | cm | S |
| 1969-07-21 | Body weight | 60.4 | kg | S |
| 1969-07-21 | Body mass index (BMI) [Ratio] | 21.4 | kg/m2 | S |
| 1969-07-21 | Systolic blood pressure | 122 | mm[Hg] | S |
| 1969-07-21 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 1969-07-21 | Heart rate | 58 | /min | S |
| 1969-07-21 | Respiratory rate | 14 | /min | S |
| 1969-07-21 | Body temperature | 36.5 | Cel | S |
| 1969-07-21 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 1969-10-20 | Body height | 168 | cm | S |
| 1969-10-20 | Body weight | 60.6 | kg | S |
| 1969-10-20 | Body mass index (BMI) [Ratio] | 21.5 | kg/m2 | S |
| 1969-10-20 | Systolic blood pressure | 122 | mm[Hg] | S |
| 1969-10-20 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 1969-10-20 | Heart rate | 58 | /min | S |
| 1969-10-20 | Respiratory rate | 14 | /min | S |
| 1969-10-20 | Body temperature | 36.6 | Cel | S |
| 1969-10-20 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 1969-06-16 | Body height | 168 | cm | S |
| 1969-06-16 | Body weight | 60.2 | kg | S |
| 1969-06-16 | Body mass index (BMI) [Ratio] | 21.3 | kg/m2 | S |
| 1969-06-16 | Systolic blood pressure | 132 | mm[Hg] | S |
| 1969-06-16 | Diastolic blood pressure | 80 | mm[Hg] | S |
| 1969-06-16 | Heart rate | 70 | /min | S |
| 1969-06-16 | Respiratory rate | 16 | /min | S |
| 1969-06-16 | Body temperature | 36.6 | Cel | S |
| 1969-06-16 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 1969-09-15 | Body height | 168 | cm | S |
| 1969-09-15 | Body weight | 60.6 | kg | S |
| 1969-09-15 | Body mass index (BMI) [Ratio] | 21.5 | kg/m2 | S |
| 1969-09-15 | Systolic blood pressure | 124 | mm[Hg] | S |
| 1969-09-15 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 1969-09-15 | Heart rate | 58 | /min | S |
| 1969-09-15 | Respiratory rate | 14 | /min | S |
| 1969-09-15 | Body temperature | 36.6 | Cel | S |
| 1969-09-15 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Purpose | Status | Provenance |
|---|---|---|---|
| 1969-04-14 | Establishing care three weeks after a heart attack and stent, with breathlessness on exertion and tiredness: examination, ECG, laboratory tests, medicines, mood screening, cardiac rehabilitation and the chest-pain action plan | finished | S |
| 1969-04-28 | Two-week review: echocardiogram, cardiology consultation the same day, the cause of the breathlessness and the antiplatelet plan | finished | S |
| 1969-05-26 | Four-week review after the change to clopidogrel: breathlessness, blood pressure, potassium and kidney function, and cardiac rehabilitation | finished | S |
| 1969-07-21 | Twelve-week review: exercise test, lipids, mood, and the return to performing | finished | S |
| 1969-10-20 | Seven-month review: antiplatelet plan to twelve months, blood pressure, kidney function, angina status and plans for the year | finished | S |
| 1969-06-16 | Same-day sick visit for a nosebleed on dual antiplatelet therapy | finished | S |
| 1969-09-15 | Periodic adult preventive visit | finished | S |
| Intervention | Status | Guideline | Provenance |
|---|---|---|---|
| Respectful, trauma-informed shared decisions: take her account of her symptoms seriously, explain each medicine and its reason plainly, write the plan down, and check costs with her before prescribing | completed | GL-AHA-WOMEN-MI-2016, GL-GWTG-DISPARITY-2016, GL-CCD-2023 | S |
| Cardiology consultation on the day of the two-week visit, with an echocardiogram, to find the cause of the breathlessness, review the antiplatelet choice and the other medicines, and advise on rehabilitation and a return to the stage | completed | GL-CCD-2023, GL-ACS-2025, GL-CMID-2026 | S |
| Dual antiplatelet therapy, aspirin 81 mg with a P2Y12 inhibitor, for twelve months from the heart attack, never stopped without speaking to cardiology; then aspirin alone | completed | GL-ACS-2025, GL-CCD-2023, GL-CMID-2026 | S |
| Atorvastatin 80 mg daily; lipid panel four to eight weeks after the start; goal LDL below 70 mg/dL with at least a 50% fall; lipoprotein(a) measured once | completed | GL-CCD-2023, GL-CMID-2026 | S |
| Metoprolol succinate for at least the first year after the heart attack; lisinopril for high blood pressure, with home readings and a target below 130/80 mmHg; potassium and creatinine one to two weeks after any dose change | completed | GL-CCD-2023, GL-CMID-2026 | S |
| Enroll in a 36-session outpatient cardiac rehabilitation program, starting within two weeks, with exercise training, nutrition, stress management and psychological support; the clinic will call her if she misses sessions | completed | GL-CCD-2023, GL-AHA-WOMEN-MI-2016, GL-CMID-2026 | S |
| Depression after a heart attack: PHQ-2 and PHQ-9 today, repeat PHQ-9 at about twelve weeks, the rehabilitation program's psychologist, and a lower threshold for treatment if symptoms rise | completed | GL-AHA-DEP-2008, GL-AHA-DEP-ACS-2014, GL-CCD-2023 | S |
| Chest-pain action plan: nitroglycerin under the tongue, and 911 if pain is not better five minutes after the first tablet; warning symptoms in women, such as breathlessness, unusual tiredness, nausea or jaw, back or arm discomfort, explained | completed | GL-AHA-WOMEN-MI-2016, GL-CCD-2023 | S |
| Costs: generic medicines in 90-day fills, the clinic social worker for debt advice and help with medicine costs, and rehabilitation sessions at times that fit her family | completed | GL-CCD-2023 | S |
| Women's cardiovascular risk: record the hysterectomy of her thirties and a possible early menopause as a risk-enhancing factor; hormone therapy is not used to prevent heart disease | completed | GL-AHA-MENO-2020, GL-AHA-WOMEN-MI-2016 | S |
| Change ticagrelor to clopidogrel for ticagrelor-related breathlessness: 600 mg loading dose 24 hours after the last ticagrelor, then 75 mg daily, without a gap in antiplatelet cover | completed | GL-ACS-2025, GL-CCD-2023 | S |
| Raise lisinopril to 10 mg daily for blood pressure above target, with potassium and creatinine one to two weeks later | completed | GL-CCD-2023, GL-CMID-2026 | S |
| Laboratory tests drawn at the rehabilitation center on session days, so that no check needs a separate trip | completed | GL-CMID-2026 | S |
| Nosebleed plan on dual antiplatelet therapy: firm pressure on the soft part of the nose for 15 minutes, saline spray and a humidifier; do not stop aspirin or clopidogrel; come in if bleeding lasts more than 30 minutes | completed | GL-AAO-EPISTAXIS-2020, GL-ACS-2025 | S |
| Graded return to the stage: rehearsals at the effort reached in rehabilitation, then full performances, with rest between shows, water, and nitroglycerin in the dressing room | completed | GL-CCD-2023 | S |
| Goal | Target | Status | Outcome | Provenance |
|---|---|---|---|---|
| Twelve months of dual antiplatelet therapy from the heart attack without interruption | 1970-03-24 | active | Seven months completed without a missed dose; changed from ticagrelor to clopidogrel without a gap | S |
| LDL cholesterol below 70 mg/dL with at least a 50% fall | 1969-07-21 | completed | LDL 62 mg/dL, a 58% fall from 146 | S |
| Blood pressure below 130/80 mmHg | 1969-05-26 | completed | 126/78 in the clinic; home average 124/76 | S |
| Complete cardiac rehabilitation and return to performing | 1969-07-21 | completed | Exercise test to about 10 METs without ischemia; graded return to rehearsals agreed | S |
| Mood: PHQ-9 below 5 by twelve weeks | 1969-07-21 | completed | PHQ-9 7 to 3 | S |